Clinical Trials Browser

Interventional × Pancreatic Neoplasms × MK 2206 × Clear all

NCT01783171 2017-08-22

Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms